Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myeloid leukemia.

R T Silver1

  • 1New York Hospital-Cornell Medical Center, New York.

Current Opinion in Oncology
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Chronic myeloid leukemia (CML) treatment was historically challenging. Recent advances in molecular genetics and cell biology offer new insights, with marrow transplantation and interferon showing clinical importance but requiring further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020
Same author

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Leukemia·2019
Same author

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.

Leukemia·2017
Same author

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Leukemia·2016
Same author

Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Molecular Genetics

Background:

  • Chronic myeloid leukemia (CML) presents challenges in understanding its origin and effective treatment.
  • Limited progress had been made in altering the natural history of CML until recently.
  • Advances in cell biology and molecular genetics provide new data on CML.

Purpose of the Study:

  • To review recent advances in understanding Chronic myeloid leukemia.
  • To discuss the clinical relevance of new morphologic, biochemical, and cytogenetic data.
  • To evaluate the role of emerging treatments in CML.

Main Methods:

  • Review of recent literature on CML.
  • Analysis of cell biology and molecular genetics findings.
  • Assessment of clinical data for novel therapies.

Related Experiment Videos

Main Results:

  • Significant clinical importance of marrow transplantation in CML treatment.
  • Recombinant interferon demonstrates clinical relevance in CML management.
  • New data from molecular and cytogenetic studies enhance understanding of CML.

Conclusions:

  • Recent scientific advances have provided new insights into Chronic myeloid leukemia.
  • Marrow transplantation and recombinant interferon are important therapeutic options.
  • Further research is needed to determine the optimal role of these treatments in CML.